These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 7951617)

  • 21. Epidemiology and screening of ovarian cancer.
    Tortolero-Luna G; Mitchell MF; Rhodes-Morris HE
    Obstet Gynecol Clin North Am; 1994 Mar; 21(1):1-23. PubMed ID: 8015758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for ovarian cancer.
    Emery J; Yaphe J; Priest P; Whiteman D
    Lancet; 1999 Aug; 354(9177):509; author reply 510. PubMed ID: 10465193
    [No Abstract]   [Full Text] [Related]  

  • 23. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.
    Skates SJ; Menon U; MacDonald N; Rosenthal AN; Oram DH; Knapp RC; Jacobs IJ
    J Clin Oncol; 2003 May; 21(10 Suppl):206s-210s. PubMed ID: 12743136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
    Havrilesky LJ; Sanders GD; Kulasingam S; Myers ER
    Gynecol Oncol; 2008 Nov; 111(2):179-87. PubMed ID: 18722004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial ovarian cancer screening.
    Stirling D; Porteous ME; Evans DG; Pichert G; Steel M
    J Clin Oncol; 2006 Feb; 24(6):e11. PubMed ID: 16484689
    [No Abstract]   [Full Text] [Related]  

  • 26. Discovery and application of protein biomarkers for ovarian cancer.
    Gagnon A; Ye B
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):9-13. PubMed ID: 18196999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for ovarian cancer: is it worth the risk?
    Bell R
    Nurs Times; 1999 Jan 20-26; 95(3):52-3. PubMed ID: 10076394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined use of tumor markers and MRI tomography in differential diagnosis of ovarian neoplasms].
    Pavlov SB; Akulina EA; Pavlova GB
    Klin Med (Mosk); 1999; 77(4):49-51. PubMed ID: 10356919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tumor markers in epithelial ovarian cancer].
    Di Cocco B; Calabretta F; Alghisi F; Salesi N; Bossone G
    Minerva Ginecol; 2003 Aug; 55(4):327-32. PubMed ID: 14581857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors.
    Begum FD; Høgdall E; Kjaer SK; Blaakaer J; Christensen IJ; Christensen L; Høgdall C
    Gynecol Oncol; 2009 May; 113(2):221-7. PubMed ID: 19261323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up of the Stockholm screening study on ovarian cancer.
    Einhorn N; Bast R; Knapp R; Nilsson B; Zurawski V; Sjövall K
    Gynecol Oncol; 2000 Dec; 79(3):466-70. PubMed ID: 11104621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Problem of uterine and ovarian cancer mass screening].
    Ohmura M; Oda M
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1907-16. PubMed ID: 12465389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA125) in patients with epithelial ovarian cancer.
    Peters-Engl C; Medl M; Ogris E; Leodolter S
    Anticancer Res; 1995; 15(6B):2727-30. PubMed ID: 8669854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for ovarian cancer.
    Jacobs I; Oram D
    Biomed Pharmacother; 1988; 42(9):589-96. PubMed ID: 3071382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ovarian cancer screening: recommendations for clinical pratice].
    Amram-Benamran ML; Cochet S; Petignat P; Sappino AP
    Rev Med Suisse; 2010 May; 6(250):1062, 1064, 1066-8. PubMed ID: 20564865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for ovarian cancer.
    Chappuis PO; Narod SA; Foulkes WD
    Lancet; 1999 Aug; 354(9177):509-10. PubMed ID: 10465194
    [No Abstract]   [Full Text] [Related]  

  • 37. Screening for ovarian cancer.
    Manassiev N
    Lancet; 1999 Aug; 354(9177):509; author reply 510. PubMed ID: 10465192
    [No Abstract]   [Full Text] [Related]  

  • 38. Early diagnosis of ovarian carcinoma: is a solution in sight?
    Lutz AM; Willmann JK; Drescher CW; Ray P; Cochran FV; Urban N; Gambhir SS
    Radiology; 2011 May; 259(2):329-45. PubMed ID: 21502390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Status of tumor markers in ovarian cancer screening.
    Bast RC
    J Clin Oncol; 2003 May; 21(10 Suppl):200s-205s. PubMed ID: 12743135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for ovarian cancer.
    MacDonald ND; Rosenthal AN; Jacobs IJ
    Ann Acad Med Singap; 1998 Sep; 27(5):676-82. PubMed ID: 9919339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.